EcoDrugPlus

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSUAMG00000016195
Gene Symbol: AGER
2 Cross references
169 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSUAMG00000004562
Gene Symbol: AKR1B1
2 Cross references
427 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSUAMG00000027452
Gene Symbol: GAA
2 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSUAMG00000025164
Gene Symbol: AOC1
2 Cross references
230 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSUAMG00000013179
Gene Symbol: AOC3
2 Cross references
318 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSUAMG00000012805
Gene Symbol: APCS
2 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSUAMG00000006090
Gene Symbol: APP
2 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSUAMG00000010531
Gene Symbol: AR
2 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSUAMG00000012710
Gene Symbol: ACE
2 Cross references
93 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSUAMG00000012044
Gene Symbol: AGTR1
2 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSUAMG00000023238
Gene Symbol: AGTR2
2 Cross references
191 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSUAMG00000011596
Gene Symbol: APLNR
2 Cross references
171 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).